title: Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment.
authors.forename: Irene C
authors.initials: IC
authors.lastname: Kuo
authors.forename: Julia A
authors.initials: JA
authors.lastname: Haller
authors.forename: Roque
authors.initials: R
authors.lastname: Maffrand
authors.forename: Ruben H
authors.initials: RH
authors.lastname: Sambuelli
authors.forename: Victor E
authors.initials: VE
authors.lastname: Reviglio
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002830:Choroid Neoplasms / Q000188:drug therapy* / Q000556:secondary; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005451:Fluorescein Angiography; D005584:Fovea Centralis; D006801:Humans; D007267:Injections; D012074:Remission Induction; D014057:Tomography, X-Ray Computed; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab